PO.MCB03.01 · 分子与细胞生物学

MEK1/2降解剂揭示MEK1/2在CRAF稳定化和成熟中不依赖激酶活性的作用

MEK1/2 degraders uncover kinase-independent role of MEK1/2 in CRAF stabilization and maturation

海报缩略图:MEK1/2降解剂揭示MEK1/2在CRAF稳定化和成熟中不依赖激酶活性的作用
编号 5988 展板 13 时间 4/21 02:00–05:00 区域 Section 23 主讲 James Duncan, PhD
分会场 RAS/MAPK Signaling, KRAS Targeting, and Adaptive Resistance
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Jason S. Wasserman1, Alison M. Kurimchak1, Carlos Herrera-Montávez1, Glenn A. Doyle1, Brandon D. Fox1, Ishadi K. M. Kodikara1, Jian Jin2, James S. Duncan1

1Fox Chase Cancer Center, Philadelphia, PA,2Icahn School of Medicine at Mount Sinai

摘要 Abstract

中文摘要
丝裂原活化蛋白激酶(MAPK)级联是一条进化上保守的信号通路,由RAS GTP酶和下游效应激酶(RAF、MEK和ERK)组成,促进细胞生长和存活。MEK1和MEK2(MEK1/2)是双特异性MAP2K激酶家族中普遍存在的成员,它们磷酸化并激活ERK1/2,控制细胞增殖。MEK1/2旁系同源物具有高度相似的激酶结构域,包括其活化环,后者由上游RAF激酶家族ARAF、BRAF和CRAF磷酸化。RAF对MEK1/2的激活已被详尽描述;RAF直接与MEK1/2相互作用并使其磷酸化,导致MEK1/2激酶激活及随后对ERK1/2的磷酸化。相比之下,上游RAF激酶(尤其是CRAF)如何被激活则高度复杂,涉及伴侣蛋白、磷酸化和RAF二聚化的协同作用,最终导致MEK1/2的磷酸化。公认的CRAF信号级联中MEK1/2仅作为CRAF的底物发挥作用,在RAS结合和RAF二聚化后与CRAF结合。然而,有证据表明MEK1可以不依赖RAS而直接调节CRAF活性,提示MEK1在CRAF循环中具有额外的功能。在此,我们利用MEK1/2蛋白水解靶向嵌合体(PROTACs)发现,MEK1/2在CRAF蛋白稳定化、成熟和激酶激活的调控中具有不依赖激酶活性的功能。我们的发现重塑了当前对CRAF激活循环的观点,确立了MEK1/2与CRAF的结合是CRAF-RAS结合之前一个所需的早期稳定化事件。因此,MEK1/2既作为CRAF的激活因子又作为其底物发挥作用。
查看英文原文 English abstract
The mitogen-activated protein kinase (MAPK) cascade is an evolutionarily conserved signaling pathway comprised of RAS GTPases, and downstream effector kinases (RAF, MEK, and ERK) that promote cell growth and survival. MEK1 and MEK2 (MEK1/2) are ubiquitous members of the dual-specificity MAP2K kinase family that phosphorylate and activate ERK1/2, controlling cellular proliferation. MEK1/2 paralogs share highly similar kinase domains, including their activation loops, which are phosphorylated by the upstream RAF family of kinases ARAF, BRAF, and CRAF. The activation of MEK1/2 by RAF is thoroughly described; RAF directly interacts with and phosphorylates MEK1/2, resulting in MEK1/2 kinase activation and subsequent phosphorylation of ERK1/2. In contrast, how the upstream RAF kinase, particularly CRAF, is activated is highly complex, involving an orchestration of chaperones, phosphorylation, and RAF dimerization, ultimately resulting in the phosphorylation of MEK1/2. The recognized CRAF signaling cascade has MEK1/2 functioning solely as a substrate of CRAF, binding to CRAF after RAS binding and RAF dimerization. However, there is evidence that MEK1 can directly regulate CRAF activity independent of RAS, suggesting that MEK1 has additional functions in the CRAF cycle. Here, using MEK1/2 proteolysis targeting chimeras (PROTACs), we discovered that MEK1/2 have kinase-independent functions in the regulation of CRAF protein stabilization, maturation, and kinase activation. Our findings reshape the current view of the CRAF activation cycle, establishing MEK1/2 binding to CRAF as an early required stabilizing event preceding CRAF-RAS engagement. Thus, MEK1/2 functions as both an activator and substrate of CRAF.
利益披露 Disclosure
J. S. Wasserman, None.. A. M. Kurimchak, None.. C. Herrera-Montávez, None.. G. A. Doyle, None.. B. D. Fox, None.. I. K. M. Kodikara, None.. J. S. Duncan, None.

← 返回 AACR 2026 检索